SNPMiner Trials by Shray Alag


SNPMiner Trials: Clinical Trial Report


Report for Clinical Trial NCT00135447

Developed by Shray Alag, 2019.
SNP Clinical Trial Gene

A Phase IV, Multicenter, Cross-sectional Study to Evaluate the I50L Substitution Among Subjects Experiencing Virologic Failure on a HAART Regimen Containing Atazanavir (ATV)

The purpose of this study is to find out the frequency of the I50L substitution among patients experiencing treatment failure on an atazanavir-containing regimen.

NCT00135447 HIV Infections
MeSH: HIV Infections



Time Perspective: Cross-Sectional

Cohort


There is one SNP

SNPs


1 I50L

A Phase IV, Multicenter, Cross-sectional Study to Evaluate the I50L Substitution Among Subjects Experiencing Virologic Failure on a HAART Regimen Containing Atazanavir (ATV). --- I50L ---

A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen The purpose of this study is to find out the frequency of the I50L substitution among patients experiencing treatment failure on an atazanavir-containing regimen. --- I50L ---

A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen The purpose of this study is to find out the frequency of the I50L substitution among patients experiencing treatment failure on an atazanavir-containing regimen. --- I50L --- --- I50L ---



HPO Nodes